Leflunomide, a Reversible Monoamine Oxidase Inhibitor

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 16, Iss. 2, 2016-08 ,pp. : 112-119

Bentham Science Publishers

Access to resources Recommend Favorite

A reversible monoamine oxidase inhibitor, Toloxatone: comparison of its physicochemical properties with those of other inhibitors including Brofaromine, Harmine, R40519 and Moclobemide

By Moureau F.   Wouters J.   Depas M.   Vercauteren D.   Durant F.   Ducrey F.   Koenig J.   Jarreau F.  

European Journal of Medicinal Chemistry, Vol. 30, Iss. 11, 1995-01 ,pp. : 823-838

Elsevier

Access to resources Recommend Favorite

Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-hydroxytryptamine neurotransmission

By Haddjeri N.   De Montigny C.   Curet O.   Blier P.  

European Journal of Pharmacology, Vol. 343, Iss. 2, 1998-02 ,pp. : 179-192

Elsevier

Access to resources Recommend Favorite

Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse

By Huang W.   Chen Y.   Shohami E.   Weinstock M.  

European Journal of Pharmacology, Vol. 366, Iss. 2, 1999-02 ,pp. : 127-135

Elsevier

Access to resources Recommend Favorite

Monoamine Oxidase Inhibitory Action of Chalcones: A Mini Review

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 16, Iss. 2, 2016-08 ,pp. : 120-136

Bentham Science Publishers

Access to resources Recommend Favorite